• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强脉冲光对难治性季节性变应性结膜炎患儿的治疗效果。

The therapeutic effect of IPL on children with refractory seasonal allergic conjunctivitis.

作者信息

Jiang Jiao, Yang Xiaoge, Du Feifan, Zheng Wei, Wang Jiancang

机构信息

Department of Ophthalmology, Hebei Children's Hospital, Shijiazhuang, 050000, Hebei, China.

出版信息

BMC Ophthalmol. 2025 Apr 17;25(1):217. doi: 10.1186/s12886-025-04058-z.

DOI:10.1186/s12886-025-04058-z
PMID:40247191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12004736/
Abstract

OBJECTIVE

To observe the effectiveness of intense pulsed light(IPL) treatment as an adjuvant treatment of refractory seasonal allergic conjunctivitis in children.

METHODS

A total of 31 patients with refractory seasonal allergic conjunctivitis who did not respond well to anti-allergic drug treatment were randomly selected to receive drug therapy combined with IPL treatment (17 patients) and drug treatment alone (14 patients) for 1 week, and the ocular surface symptom questionnaire and ocular surface sign score were performed before and after treatment, respectively.

RESULT

After treatment, the IPL group had significantly lower scores in eye rubbing, blinking, eye itching, discharge, tearing, and total scores than before treatment (P < 0.05), while there was no significant difference in foreign body sense scores before and after treatment (P > 0.05). There were no significant differences in eye rubbing, blinking, eye itching, discharge, foreign body sensation, tearing, and total score between the control group after treatment (P > 0.05). After treatment, the scores of ocular signs in the IPL group and the control group were lower than those before treatment, and the difference was statistically significant (P < 0.01).

CONCLUSION

IPL therapy is effective in improving ocular surface symptoms in children with refractory seasonal allergic conjunctivitis, especially in suppressing eye itching, with good results.

摘要

目的

观察强脉冲光(IPL)治疗作为儿童难治性季节性过敏性结膜炎辅助治疗的效果。

方法

随机选取31例对抗过敏药物治疗反应不佳的难治性季节性过敏性结膜炎患者,分别接受药物联合IPL治疗(17例)和单纯药物治疗(14例),为期1周,分别在治疗前后进行眼表症状问卷和眼表体征评分。

结果

治疗后,IPL组在揉眼、眨眼、眼痒、分泌物、流泪及总分方面的得分均显著低于治疗前(P<0.05),而治疗前后异物感得分差异无统计学意义(P>0.05)。治疗后对照组在揉眼、眨眼、眼痒、分泌物、异物感、流泪及总分方面与IPL组比较,差异均无统计学意义(P>0.05)。治疗后,IPL组和对照组的眼表体征评分均低于治疗前,差异有统计学意义(P<0.01)。

结论

IPL治疗可有效改善儿童难治性季节性过敏性结膜炎的眼表症状,尤其在抑制眼痒方面效果良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e20/12004736/0e0d26450a0f/12886_2025_4058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e20/12004736/b919a2fc82ad/12886_2025_4058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e20/12004736/b0ecb5d5a003/12886_2025_4058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e20/12004736/2be12a6a0a33/12886_2025_4058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e20/12004736/0e0d26450a0f/12886_2025_4058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e20/12004736/b919a2fc82ad/12886_2025_4058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e20/12004736/b0ecb5d5a003/12886_2025_4058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e20/12004736/2be12a6a0a33/12886_2025_4058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e20/12004736/0e0d26450a0f/12886_2025_4058_Fig4_HTML.jpg

相似文献

1
The therapeutic effect of IPL on children with refractory seasonal allergic conjunctivitis.强脉冲光对难治性季节性变应性结膜炎患儿的治疗效果。
BMC Ophthalmol. 2025 Apr 17;25(1):217. doi: 10.1186/s12886-025-04058-z.
2
A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis.0.1% 奥洛他定滴眼液与安慰剂对照治疗季节性变应性结膜炎和鼻结膜炎体征及症状的随机、双盲、平行组比较
Clin Ther. 2003 Mar;25(3):931-47. doi: 10.1016/s0149-2918(03)80115-7.
3
[Clinical study of Supranettes pads in the treatment of seasonal or perennial allergic conjunctivitis in children].[Supranettes护垫治疗儿童季节性或常年性过敏性结膜炎的临床研究]
J Fr Ophtalmol. 2006 Jun;29(6):593-8. doi: 10.1016/s0181-5512(06)73819-0.
4
[First Hungarian report of olopatadine eyedrop therapy in children and adults suffering from seasonal allergic conjunctivitis].[匈牙利关于奥洛他定滴眼液治疗儿童和成人季节性过敏性结膜炎的首份报告]
Orv Hetil. 2006 Sep 10;147(36):1741-3.
5
Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.用于治疗季节性和常年性过敏性结膜炎的局部用抗组胺药和肥大细胞稳定剂。
Cochrane Database Syst Rev. 2015 Jun 1;2015(6):CD009566. doi: 10.1002/14651858.CD009566.pub2.
6
[Effectiveness of olopatadine therapy in seasonal allergic conjunctivitis].奥洛他定治疗季节性变应性结膜炎的疗效
Oftalmologia. 2009;53(4):67-71.
7
A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.0.1%盐酸奥洛他定滴眼液与2%色甘酸钠滴眼液治疗季节性过敏性结膜炎的疗效及耐受性比较
Clin Ther. 2002 Oct;24(10):1561-75. doi: 10.1016/s0149-2918(02)80060-1.
8
Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.评估0.2%奥洛他定滴眼液对过敏性结膜炎合并干眼患者眼表的影响。
Curr Med Res Opin. 2008 Feb;24(2):441-7. doi: 10.1185/030079908x261078.
9
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.0.1%盐酸奥洛他定、0.025%富马酸酮替芬、0.05%盐酸依匹斯汀、0.05%依美斯汀和0.1%醋酸氟米龙滴眼液治疗季节性过敏性结膜炎的疗效:一项安慰剂对照的环境试验
Acta Ophthalmol. 2009 Aug;87(5):549-54. doi: 10.1111/j.1755-3768.2008.01265.x. Epub 2008 Jul 9.
10
Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.在结膜过敏原激发模型中比较富马酸酮替芬滴眼液单药、地氯雷他定单药及其联合用药对季节性变应性鼻结膜炎体征和症状的抑制作用:一项双盲、安慰剂对照和阳性对照试验。
Clin Ther. 2003 Jul;25(7):1975-87. doi: 10.1016/s0149-2918(03)80199-6.

本文引用的文献

1
Prevalence of symptomatic dry eye and influencing factors among Chinese adolescents: A cross-sectional study.中国青少年症状性干眼的患病率及影响因素:一项横断面研究。
PLoS One. 2024 Oct 29;19(10):e0312725. doi: 10.1371/journal.pone.0312725. eCollection 2024.
2
Safety and efficacy of a novel 0.5% epinastine topical eyelid cream in allergic conjunctivitis: a phase 3 trial.新型 0.5%埃匹司他丁眼部乳膏治疗过敏性结膜炎的安全性和有效性:一项 3 期临床试验。
Jpn J Ophthalmol. 2024 Nov;68(6):651-659. doi: 10.1007/s10384-024-01108-9. Epub 2024 Sep 11.
3
Impact of temperature and relative humidity variability on children's allergic diseases and critical time window identification.
温度和相对湿度变异性对儿童过敏性疾病的影响及关键时间窗识别
BMC Public Health. 2024 Jul 31;24(1):2068. doi: 10.1186/s12889-024-19573-9.
4
Allergic Conjunctivitis: Review of Current Types, Treatments, and Trends.过敏性结膜炎:当前类型、治疗方法及趋势综述
Life (Basel). 2024 May 21;14(6):650. doi: 10.3390/life14060650.
5
Biomarkers of ocular allergy and dry eye disease.眼过敏和干眼疾病的生物标志物。
Rom J Ophthalmol. 2023 Jul-Sep;67(3):250-259. doi: 10.22336/rjo.2023.42.
6
Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study.0.6% 比拉斯汀滴眼液的安全性和耐受性:一项为期8周的III期研究
Clin Ophthalmol. 2023 Mar 4;17:735-746. doi: 10.2147/OPTH.S398168. eCollection 2023.
7
Bilastine 0.6% Preservative-free Eye Drops: A Once-daily Treatment for Allergic Conjunctivitis.贝乐司他 0.6% 无防腐剂滴眼液:一种治疗过敏性结膜炎的每日一次治疗方案。
J Investig Allergol Clin Immunol. 2024 Jun 17;34(3):167-176. doi: 10.18176/jiaci.0894. Epub 2023 Feb 23.
8
Intense Pulsed Light Attenuates Oxidative Stress in Perennial Allergic Conjunctivitis.强脉冲光减轻常年性变应性结膜炎中的氧化应激。
Photobiomodul Photomed Laser Surg. 2023 Jan;41(1):17-25. doi: 10.1089/photob.2022.0063.
9
Intense Pulsed Light Treatment for Itch Associated with Allergic Keratoconjunctivitis: A Retrospective Study of 35 Cases.强脉冲光治疗变应性角结膜炎相关瘙痒:35 例回顾性研究。
Photobiomodul Photomed Laser Surg. 2021 Mar;39(3):196-203. doi: 10.1089/photob.2020.4826. Epub 2021 Feb 23.
10
Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.强脉冲光(IPL)疗法治疗睑板腺功能障碍。
Cochrane Database Syst Rev. 2020 Mar 18;3(3):CD013559. doi: 10.1002/14651858.CD013559.